Topical tacrolimus is effective against eczema in Wiskott-Aldrich syndrome (WAS)

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 2, 2007, Pages 312-314

  Bienemann, Klaus ^a   Gudowius, Sonja ^a   Niehues, Tim ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Eczema; Primary immunodeficiency; Protopic; Therapy; Topical tacrolimus; Wiskott Aldrich syndrome (WAS)

Indexed keywords

CLEMASTINE; PREDNISOLONE; STEROID; TACROLIMUS; TRICLOSAN;

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ECZEMA; HUMAN; INFANT; KIDNEY DYSFUNCTION; MALE; NEUROTOXICITY; PRIORITY JOURNAL; SKIN MANIFESTATION; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

ADMINISTRATION, CUTANEOUS; ECZEMA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; TACROLIMUS; TREATMENT OUTCOME; WISKOTT-ALDRICH SYNDROME;

EID: 33847202966     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00044.x     Document Type: Article

References (10)

1. Orange JS, Stone KD, Turvey SE, Krzewski K. The Wiskott-Aldrich syndrome [review]. Cell Mol Life Sci 2004; 61: 2361-85.
2. Imai K, Nonoyama S, Ochs HD. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype [review]. Curr Opin Allergy Clin Immunol 2003; 3: 427-36.
3. Notarangelo LD, Mori L. Wiskott-Aldrich syndrome: another piece in the puzzle [review]. Clin Exp Immunol 2005; 139: 173-5.
4. Notarangelo LD, Ochs HD. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Curr Opin Immunol 2003; 15: 585-91.
5. Conley ME, Saragoussi D, Notarangelo L, Etzioni A, Casanova JL. An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 2003; 109: 272-7.
6. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-21.
7. Kang S, Paller A, Soter N, Satoi Y, Rico MJ, Hanifin JM. Safe treatment of head/neck AD with tacrolimus ointment. J Dermatolog Treat 2003; 14: 86-94.
8. Soter NA, Fleischer AB Jr, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001; 44: 39-46.
9. Boguniewicz M, Fiedler VC, Raimer S, Lawrence ID, Leung DY, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998; 102: 637-44.
10. Kameda G, Kramm C, Stege H, Hermsen D, Krutmann J, Niehues T. Unexpected high serum levels of tacrolimus after a single topical application in an infant. J Pediatr 2003; 143: 280.